214486-62-1

Basic information

• Product Name: 4-(4-chloro-2-fluoro-5-hydroxy-phenylamino)-7-methoxy-6-(3-morpholin-4-yl)-propoxyl-quinoline-3-carbonitrile
• Synonyms: 4-(4-chloro-2-fluoro-5-hydroxy-phenylamino)-7-methoxy-6-(3-morpholin-4-yl)-propoxyl-quinoline-3-carbonitrile
• CAS NO: 214486-62-1
• Molecular Weight: 486.93
• Mol File: 214486-62-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(4-chloro-2-fluoro-5-hydroxy-phenylamino)-7-methoxy-6-(3-morpholin-4-yl)-propoxyl-quinoline-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-chloro-2-fluoro-5-hydroxy-phenylamino)-7-methoxy-6-(3-morpholin-4-yl)-propoxyl-quinoline-3-carbonitrile(214486-62-1)
• EPA Substance Registry System: 4-(4-chloro-2-fluoro-5-hydroxy-phenylamino)-7-methoxy-6-(3-morpholin-4-yl)-propoxyl-quinoline-3-carbonitrile(214486-62-1)

Safety Data

• Hazardous Substances Data: 214486-62-1(Hazardous Substances Data)

Upstream product

• 214472-37-4 4-methoxy-5-(3-morpholinylpropoxy)-2-nitrobenzoic acid methyl ester 
• 214472-41-0 methyl 5-(3-morpholinopropoxy)-2-amino-4-methoxy-benzoate 
• 214472-17-0 4-methoxy-5-[3-(4-morpholinyl)propoxy]benzoic acid methyl ester 
• 645-08-9 Isovanillic acid 
• 6702-50-7 3-hydroxy-4-methoxybenzoate 
• 252264-46-3 ethyl 2-(dimethylaminomethyleneamino)-4-methoxy-5-(3-morpholin-4-yl-propoxy)benzoate 
• 84478-72-8 4-chloro-2-fluoro-5-hydroxyaniline 
• 214475-85-1 4-chloro-7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinoline-3-carbonitrile 

Relevant articles and documents

USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS

This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula (1); wherein R1, R2, R3, R4, X, Y, and n are defined hereinbefore, or a pharmaceutically acceptable salt thereof.

Method of treating or inhibiting colonic polyps

This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula 1 wherein:R1, R2, R3, R4, X, Y, and n are as defined hereinbefore, or a pharmaceutically acceptable salt thereof.